Virtual Medical Scholar Lecture: Translational Investigations of Clostridioides difficile Infection
Vincent Young, M.D., Ph.D.
William Henry Fitzbutler Collegiate Professor
Department of Internal Medicine, Division of Infectious Diseases
Department of Microbiology and Immunology
University of Michigan Medical School
Virtual Timothy A. Johnson Medical Scholar Lecture: Translational Investigations of Clostridioides difficile Infection
Archived video
About this Seminar
Clostridioides difficile infection (CDI) is the exemplar of a disease that is reflective of the complex interactions between the pathogen, host and the indigenous microbiota. Furthermore, as a hospital-acquired infection, the epidemiology of the pathogen is critically important in developing strategies to limit the burden of disease in the population. CDI following the administration of antibiotics has been estimated to be the costliest healthcare-associated infection. In the United States, CDI is responsible for an estimated $5 billion in increased healthcare cost annually, due to an estimated 500,000 cases and up to 29,000 deaths. Dr. Young's previous work and the work of others has demonstrated that susceptibility to CDI and subsequent outcome of infection is driven by the myriad interactions between the host, microbiota and pathogen, all in the context of the healthcare environment. This complex interplay lends itself to study via a translational, systems biology approach. Dr. Young will provide an overview of CDI and discuss how we have been studying this infection with a transdisciplinary team that involves investigators with diverse skills and interests including microbiology, infectious diseases, computer science, epidemiology, microbial ecology and immunology.
Additional Details
This is a free event hosted by the Fralin Biomedical Research Institute and the Virginia Tech Carilion School of Medicine. The Timothy A. Johnson Medical Scholar Lecture Series hosts clinician scientists who are exploring frontiers of medicine. These lectures are principally intended for Virginia Tech Carilion School of Medicine students and Virginia Tech students in Translational Biology, Medicine, and Health graduate program. Virginia Tech and Carilion Clinic faculty, staff, and students may also attend.
You May Also Be Interested In...
-
Home Item
Why Measure? , homeSept. 17, 2026, 5:30 p.m. (Reception at 5 p.m.) | Christopher S. Hourigan, DM, DPhil, FRCP, Professor and Director, Cancer Research Center — D.C., Fralin Biomedical Research Institute | Maury Strauss Distinguished Public Lecture
-
Home Item
Brown Adipose Tissue as a Mediator of Cardiovascular Health , homeSept. 18, 2026, 11:00 a.m. | Kristin Stanford, Ph.D., FAHA, Professor, Department of Surgery; William D. and Jacquelyn L. Wells Chair, Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University Wexner Medical Center | Co-Sponsored by the Fralin Biomedical Research Institute and the Center for Exercise Medicine Research
-
Home Item
mTor Signaling in Pulmonary Vascular Disease: Bench to Bedside and Back , homeSept. 25, 2026, 11:00 a.m. | Elena Goncharova, Ph.D., ATSF, FAHA, Professor, Department of Internal Medicine; Director, Pulmonary Vascular Disease Program, UC Davis School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute and the Center for Vascular and Heart Research
-
Home Item
How Can Research Inform Better Public Policy Towards Addiction? , homeOct. 2, 2026, 11:00 a.m. | Keith Humphreys, OBE, Ph.D., Esther Ting Memorial Professor, Department of Psychiatry, Stanford University School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute and the Center for Health Behaviors Research
-
Home Item
Exercise, the Fountain of Youth? , homeOct. 15, 2026, 5:30 p.m. (Reception at 5 p.m.) | Zhen Yan, Ph.D., Professor and Director, Center for Exercise Medicine Research, Fralin Biomedical Research Institute at VTC | Maury Strauss Distinguished Public Lecture
-
Home Item
Data-Driven Discovery of Secreted Proteins as Cancer Immunotherapies , homeOct. 16, 2026, 11:00 a.m. | Peng Jiang, Ph.D., Senior Investigator, National Cancer Institute, National Institutes of Health | Co-Sponsored by the Fralin Biomedical Research Institute and the Cancer Research Center — D.C.